# Matthew I. Kim

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/matthew-i-kim/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,076 |
| Field | Thyroid Cancer Diagnosis and Treatment |
| h-index | 15 |
| i10-index | 15 |
| Last Known Institution | Brigham and Women's Hospital |
| OpenAlex ID | https://openalex.org/A5047594780 |
| Works | 25 |

## Researcher papers

- [The Influence of Patient Age on Thyroid Nodule Formation, Multinodularity, and Thyroid Cancer Risk](https://scholariq.org/papers/the-influence-of-patient-age-on-thyroid-nodule-formation-multinodularity-and/)
- [Bethesda Categorization of Thyroid Nodule Cytology and Prediction of Thyroid Cancer Type and Prognosis](https://scholariq.org/papers/bethesda-categorization-of-thyroid-nodule-cytology-and-prediction-of-thyroid/)
- [The variable phenotype and low-risk nature of RAS-positive thyroid nodules](https://scholariq.org/papers/the-variable-phenotype-and-low-risk-nature-of-ras-positive-thyroid-nodules/)
- [Independent Comparison of the Afirma Genomic Sequencing Classifier and Gene Expression Classifier for Cytologically Indeterminate Thyroid Nodules](https://scholariq.org/papers/independent-comparison-of-the-afirma-genomic-sequencing-classifier-and-gene/)
- [Qualifiers of atypia in the cytologic diagnosis of thyroid nodules are associated with different Afirma gene expression classifier results and clinical outcomes](https://scholariq.org/papers/qualifiers-of-atypia-in-the-cytologic-diagnosis-of-thyroid-nodules-are/)
- [A Cohort Analysis of Clinical and Ultrasound Variables Predicting Cancer Risk in 20,001 Consecutive Thyroid Nodules](https://scholariq.org/papers/a-cohort-analysis-of-clinical-and-ultrasound-variables-predicting-cancer-risk-in/)
- [A phase II study of nivolumab (N) plus ipilimumab (I) in radioidine refractory differentiated thyroid cancer (RAIR DTC) with exploratory cohorts in anaplastic (ATC) and medullary thyroid cancer (MTC).](https://scholariq.org/papers/a-phase-ii-study-of-nivolumab-n-plus-ipilimumab-i-in-radioidine-refractory/)
- [Differential Growth Rates of Benign vs. Malignant Thyroid Nodules](https://scholariq.org/papers/differential-growth-rates-of-benign-vs-malignant-thyroid-nodules/)
- [Quantitative Analysis of the Benefits and Risk of Thyroid Nodule Evaluation in Patients ≥70 Years Old](https://scholariq.org/papers/quantitative-analysis-of-the-benefits-and-risk-of-thyroid-nodule-evaluation-in/)
- [Diagnostic use of Molecular Markers In the Evaluation of Thyroid Nodules](https://scholariq.org/papers/diagnostic-use-of-molecular-markers-in-the-evaluation-of-thyroid-nodules/)
- [Patient-Reported Symptom Relief from Percutaneous Benign Thyroid Nodule Radiofrequency Ablation in Routine Clinical Care](https://scholariq.org/papers/patient-reported-symptom-relief-from-percutaneous-benign-thyroid-nodule/)

## Researcher topics

- [Thyroid Cancer Diagnosis and Treatment](https://scholariq.org/topics/thyroid-cancer-diagnosis-and-treatment/)
- [Thyroid Disorders and Treatments](https://scholariq.org/topics/thyroid-disorders-and-treatments/)
- [Thyroid and Parathyroid Surgery](https://scholariq.org/topics/thyroid-and-parathyroid-surgery/)
- [Health Literacy and Information Accessibility](https://scholariq.org/topics/health-literacy-and-information-accessibility/)
- [Electronic Health Records Systems](https://scholariq.org/topics/electronic-health-records-systems/)

## Researcher university

- [Brigham and Women's Hospital](https://scholariq.org/institutions/brigham-and-women-s-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.